Literature DB >> 23579385

The protective effect of amiodarone in lung tissue of cecal ligation and puncture-induced septic rats: a perspective from inflammatory cytokine release and oxidative stress.

Beyzagul Polat1, Elif Cadirci, Zekai Halici, Yasin Bayir, Deniz Unal, Bulent Caglar Bilgin, Tugba Nurcan Yuksel, Serhat Vancelik.   

Abstract

Sepsis is a serious medical condition that is characterized by a whole-body inflammatory state and the presence of a known or suspected infection. Amiodarone is a class III antiarrhythmic agent, a multichannel blocker (Ca++, Na+, and K+), and a noncompetitive α- and β-adrenergic blocker in cardiac cells. The present study aimed to determine whether amiodarone was protective against experimentally induced cecal ligation and puncture sepsis in rat lung tissue. The relationship between its probable protective effect and antioxidant/anticytokine action biochemically and histopathologically was also examined. Five groups of rats were used, each composed of 20 rats: (1) the sham-operated control group; (2) the CLP group; (3) the 25-mg/kg amiodarone-treated control healthy group; (4) the 50-mg/kg amiodarone-treated CLP group; and (5) the 50-mg/kg amiodarone-treated CLP group. A CLP polymicrobial sepsis model was applied to the rats. All groups were sacrificed 16 h later, and lung and blood samples were analyzed histopathologically and biochemically. Twenty-five and 50 mg/kg amiodarone decreased the level of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α in serum and 8-iso-prostaglandin F2α level in lung tissue. They increased the activities of superoxide dismutase and levels of total glutathione in lung tissues of rats. Histopathological scores and examinations were in accordance with the biochemical results. Histopathological analysis revealed significant differences in inflammation scores between the sepsis group and the other groups. The CLP + amiodarone 50 mg/kg group had the lowest inflammation score among CLP groups. Our results indicate that administration of amiodarone prevented oxidative stress and cytokine action and protected lung tissue during sepsis cascade.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579385     DOI: 10.1007/s00210-013-0862-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  50 in total

Review 1.  Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo.

Authors:  J A Lawson; J Rokach; G A FitzGerald
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

Review 2.  Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family.

Authors:  K Kuwano; N Hara
Journal:  Am J Respir Cell Mol Biol       Date:  2000-02       Impact factor: 6.914

3.  Biomarkers of free radical injury during spinal cord ischemia.

Authors:  S Basu; A Hellberg; A T Ulus; J Westman; S Karacagil
Journal:  FEBS Lett       Date:  2001-11-09       Impact factor: 4.124

4.  Lung injury by amiodarone, an antiarrhythmic drug, in male rats.

Authors:  B Padmavathy; S Niranjali; H Devaraj
Journal:  Indian J Exp Biol       Date:  1992-07       Impact factor: 0.818

Review 5.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

6.  Protection by metal complexes with SOD-mimetic activity against oxidative gastric injury induced by indomethacin and ethanol in rats.

Authors:  M A El-Missiry; I H El-Sayed; A I Othman
Journal:  Ann Clin Biochem       Date:  2001-11       Impact factor: 2.057

Review 7.  Sepsis and cytokines: current status.

Authors:  T S Blackwell; J W Christman
Journal:  Br J Anaesth       Date:  1996-07       Impact factor: 9.166

8.  Natural killer cell activity in a rat model of amiodarone-induced interstitial lung disease.

Authors:  J P Karpel; S Mitsudo; A J Norin
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

9.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003.

Authors:  Viktor Y Dombrovskiy; Andrew A Martin; Jagadeeshan Sunderram; Harold L Paz
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

10.  Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis.

Authors:  J M Antonini; C M McCloud; M J Reasor
Journal:  Environ Health Perspect       Date:  1994-04       Impact factor: 9.031

View more
  6 in total

1.  Pleiotropic actions of amiodarone: still puzzling after half a century.

Authors:  Jordi Heijman; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-09       Impact factor: 3.000

Review 2.  Sepsis and Septic Shock: Current Treatment Strategies and New Approaches.

Authors:  Gizem Polat; Rustem Anil Ugan; Elif Cadirci; Zekai Halici
Journal:  Eurasian J Med       Date:  2017-02

3.  Urotensin receptors as a new target for CLP induced septic lung injury in mice.

Authors:  Elif Cadirci; Rustem Anil Ugan; Busra Dincer; Betul Gundogdu; Irfan Cinar; Erol Akpinar; Zekai Halici
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-24       Impact factor: 3.000

4.  What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury.

Authors:  Erol Akpinar; Zekai Halici; Elif Cadirci; Yasin Bayir; Emre Karakus; Muhammet Calik; Atilla Topcu; Beyzagul Polat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-09       Impact factor: 3.000

5.  Interleukin IL-5 alleviates sepsis-induced acute lung injury by regulating the immune response in rats.

Authors:  Beichun Wei; Yu Chen; Wangmei Zhou; Xu Li; Lei Shi; Shengwu Liao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?

Authors:  Fabian Sanchis-Gomar; Carl J Lavie; Daniel P Morin; Carme Perez-Quilis; Jari A Laukkanen; Marco V Perez
Journal:  Am J Cardiovasc Drugs       Date:  2020-10       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.